These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1578 related articles for article (PubMed ID: 33950288)

  • 1. The interplay between the immune system and SARS-CoV-2 in COVID-19 patients.
    Shabbir S; Raza MH; Arshad M; Khan MJ
    Arch Virol; 2021 Aug; 166(8):2109-2117. PubMed ID: 33950288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
    Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
    Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients.
    Bonam SR; Kaveri SV; Sakuntabhai A; Gilardin L; Bayry J
    Cell Rep Med; 2020 May; 1(2):100016. PubMed ID: 32562483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice.
    Ghasemzadeh M; Ghasemzadeh A; Hosseini E
    Hum Immunol; 2022 Jan; 83(1):86-98. PubMed ID: 34583856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinflammation and Immune Response Generation in COVID-19.
    Mishra KP; Singh AK; Singh SB
    Neuroimmunomodulation; 2020; 27(2):80-86. PubMed ID: 33341814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.
    Anka AU; Tahir MI; Abubakar SD; Alsabbagh M; Zian Z; Hamedifar H; Sabzevari A; Azizi G
    Scand J Immunol; 2021 Apr; 93(4):e12998. PubMed ID: 33190302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
    Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
    J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Exhaustion Levels of NK and CD8
    Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
    Front Immunol; 2020; 11():580237. PubMed ID: 33154753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
    Pinheiro MM; Fabbri A; Infante M
    Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 21st Century Evil: Immunopathology and New Therapies of COVID-19.
    Silva TF; Tomiotto-Pellissier F; Sanfelice RA; Gonçalves MD; da Silva Bortoleti BT; Detoni MB; Rodrigues ACJ; Carloto ACM; Concato VM; Siqueira EDS; Costa IN; Pavanelli WR; Conchon-Costa I; Miranda-Sapla MM
    Front Immunol; 2020; 11():562264. PubMed ID: 33193331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology.
    Song NJ; Allen C; Vilgelm AE; Riesenberg BP; Weller KP; Reynolds K; Chakravarthy KB; Kumar A; Khatiwada A; Sun Z; Ma A; Chang Y; Yusuf M; Li A; Zeng C; Evans JP; Bucci D; Gunasena M; Xu M; Liyanage NPM; Bolyard C; Velegraki M; Liu SL; Ma Q; Devenport M; Liu Y; Zheng P; Malvestutto CD; Chung D; Li Z
    J Hematol Oncol; 2022 Jan; 15(1):5. PubMed ID: 35012610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?
    Ahmed F; Jo DH; Lee SH
    Front Immunol; 2020; 11():586765. PubMed ID: 33365027
    [No Abstract]   [Full Text] [Related]  

  • 14. CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines
    Ma MT; Badeti S; Chen CH; Kim J; Choudhary A; Honnen B; Reichman C; Calianese D; Pinter A; Jiang Q; Shi L; Zhou R; Xu H; Li Q; Gause W; Liu D
    Front Immunol; 2021; 12():652223. PubMed ID: 34367128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathology of Hyperinflammation in COVID-19.
    Gustine JN; Jones D
    Am J Pathol; 2021 Jan; 191(1):4-17. PubMed ID: 32919977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review on therapeutic targets for COVID-19: insights from cytokine storm.
    Mélo Silva Júnior ML; Souza LMA; Dutra REMC; Valente RGM; Melo TS
    Postgrad Med J; 2021 Jun; 97(1148):391-398. PubMed ID: 33008960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: Immunology, Immunopathogenesis and Potential Therapies.
    Bhardwaj A; Sapra L; Saini C; Azam Z; Mishra PK; Verma B; Mishra GC; Srivastava RK
    Int Rev Immunol; 2022; 41(2):171-206. PubMed ID: 33641587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
    Yongzhi X
    Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perforin, COVID-19 and a possible pathogenic auto-inflammatory feedback loop.
    Cunningham L; Kimber I; Basketter D; Simmonds P; McSweeney S; Tziotzios C; McFadden JP
    Scand J Immunol; 2021 Nov; 94(5):e13102. PubMed ID: 34755902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
    Mohammed RN; Tamjidifar R; Rahman HS; Adili A; Ghoreishizadeh S; Saeedi H; Thangavelu L; Shomali N; Aslaminabad R; Marofi F; Tahavvori M; Danshina S; Akbari M; Ercan G
    Cell Commun Signal; 2022 Jun; 20(1):79. PubMed ID: 35655192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 79.